Kim, Grace Hyun J.

ChatGPT in radiology: A systematic review of performance, pitfalls, and future perspectives

Keshavarz, P., Bagherieh, S., Nabipoorashrafi, S. A., Chalian, H., Rahsepar, A. A., Kim, G. H. J., Hassani, C., Raman, S. S., & Bedayat, A. (2024) · Diagnostic and Interventional Imaging

Artificial Intelligence in Healthcare and EducationRadiology practices and education

Cited by 132

Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

Lancaster, L., Cottin, V., Ramaswamy, M., Wuyts, W. A., Jenkins, R. G., Scholand, M. B., Kreuter, M., Valenzuela, C., Ryerson, C. J., Goldin, J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 80

Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease

Martyanov, V., Kim, G.-H. J., Hayes, W., Du, S., Ganguly, B. J., Sy, O., Lee, S. K., Bogatkevich, G. S., Schieven, G. L., Schiopu, E., et al. (2017) · PLOS ONE

Systemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 71

Translating AI to Clinical Practice: Overcoming Data Shift with Explainability

Choi, Y., Yu, W., Nagarajan, M. B., Teng, P., Goldin, J. G., Raman, S. S., Enzmann, D. R., Kim, G. H. J., & Brown, M. S. (2023) · RadioGraphics

Explainable Artificial Intelligence (XAI)Artificial Intelligence in Healthcare and Education

Cited by 65

Late Breaking Abstract - Safety, tolerability and antifibrotic activity of bexotegrast: Phase 2a INTEGRIS-IPF study (NCT04396756)

Wuyts, W. A., Valenzuela, C., Jenkins, G., Goldin, J. G., Kim, G. H. J., Jurek, M., Turner, S., Decaris, M., Barnes, C. N., Lefebvre, É., et al. (2023) · Idiopathic interstitial pneumonias

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments

Cited by 7

Improved quality of life, reduced quantitative lung fibrosis in a trial of inhaled pirfenidone for idiopathic pulmonary fibrosis

Kim, G. H. J., Woodhead, F. A., Nair, D., Bao, H., Lazarus, H. M., Conoscenti, C. S., & Goldin, J. G. (2026) · BMC Pulmonary Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 1